Welcome to NCCN.org
Already have an account?
Log in for a personalized experience.
New Visitors:
Please create a free account to access clinical content and log in for a personalized experience.
Access the new NCCN Guidelines for Patients: Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer
Now available in the March 2025 issue: View the latest research on patient-reported outcomes among older adults with aggressive lymphomas, “off-label” use of checkpoint inhibitors, a novel curriculum for training on cannabis use in oncology, association between survival and nonfatal self-injury after a cancer diagnosis, quality of life among patients with pancreatic cancer, and more.
Continuously updated cancer care recommendations downloaded more than 16 million times annually and used across an integrated suite of resources.
Offering more than 140 activities annually designed to engage oncology care team members to improve everyday practice.
Working with multiple stakeholders to ensure use of NCCN Guidelines in health policy and coverage determination and patient access to guideline-concordant care.
Engaging hundreds of key stakeholders to disseminate NCCN content, enhance collaborative efforts, and expand awareness of NCCN programs and resources.
Fostering innovation and knowledge discovery that improve the lives of patients with cancer.
Library of global resources ensures providers and patients have access to the most up-to-date standards in cancer care around the world. These resources have been used in more than 190 countries.
NCCN Member Institutions
NCCN is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives.
The NCCN Foundation
Supports millions of people facing cancer through the development and distribution of the NCCN Guidelines for Patients and other free cancer resources.  The NCCN Foundation also ensures cancer research innovation through the NCCN Foundation Young Investigator Awards Program.

NCCN Website Supporters

AstraZenecaAstraZeneca GSKGSK KiteKite Regeneron